Nevertheless, miR-203 has also been implemented in esophageal and acute lymphoblastic leukemia cells that results in suppression of proliferative activity by targeting DNp63 and ABL1 [44, 45].Consistent with these reports, we have also found endogenous miR-203 is significantly down regulated in glioblastoma cell lines as compared to normal cell. The gene discussed is ABL1; the disease is glioblastoma.